All > Illinois > Florida

ZB012 for IgG4-Related Disease

Phase-Based Progress Estimates
2
Effectiveness
3
Safety
IgG4-Related DiseaseObexelimab - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study aims to examine the efficacy and safety of obexelimab for the prevention of flare of IgG4-related disease (IgG4-RD)

Eligible Conditions
  • IgG4-Related Disease

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Similar Trials

1
Belantamab mafodotin
1
Dapansutrile
1
Belantamab Mafodotin, Cyclophosphamide and Dexamethasone

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Randomization to Week 52

Randomization to Week 52
measure

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Belantamab mafodotin
2
Dapansutrile
1
Belantamab Mafodotin, Cyclophosphamide and Dexamethasone

Trial Design

2 Treatment Groups

ZB012
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

200 Total Participants · 2 Treatment Groups

Primary Treatment: ZB012 · Has Placebo Group · Phase 3

ZB012
Drug
Experimental Group · 1 Intervention: Obexelimab · Intervention Types: Drug
Placebo
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: randomization to week 52

Who is running the clinical trial?

Zenas BioPharma (USA), LLCLead Sponsor
2 Previous Clinical Trials
64 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Patients must demonstrate active manifestations of IgG4-RD that necessitate the commencement or intensification of GC therapy.
You are at least 18 years old, regardless of gender.
You must meet the current ACR/EULAR standards for diagnosis of IgG4-RD.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top